Public filings / AVTX on Yahoo Finance (opens in a new tab)
AVTX: insider buying, 13F holders, analyst moves
Avalo Therapeutics, Inc.
A summary of public filings about Avalo Therapeutics, Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
7 of our 100 managers hold AVTX
Combined reported value $191.9M.
Holders among our 100 managers: 0 in Q3 2023, 7 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deep Track Capital | $66.7M | 0.98% | New |
| Farallon Capital | $46.2M | 0.27% | Added |
| Avoro Capital Advisors | $43.1M | 0.39% | Added |
| RA Capital | $18.5M | 0.16% | Added |
| Baker Bros. Advisors | $10.2M | 0.05% | New |
| Perceptive Advisors | $4.1M | 0.06% | Added |
| RTW Investments | $3.2M | 0.03% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.